期刊
VACCINE
卷 24, 期 31-32, 页码 5904-5911出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2006.04.002
关键词
coccidioides; vaccine; recombinant expression protein; mouse; cell-mediated immunity
资金
- NIAID NIH HHS [1P01AI061310-01, 5P01AI37232-06] Funding Source: Medline
Two recombinant antigens which individually protect mice from lethal intranasal infection were studied in combination, either as a mixture of two separately expressed proteins or as a single chimeric expression product. Mice vaccinated with either combination survived longer than mice given single antigens. Immunized mice also exhibited specific IgG immunoglobulins and yielded splenocytes which produced interferon-gamma in response to either antigen. The chimeric antigen has the practical advantage of offering enhanced protection from multiple components without increasing production costs. (c) 2006 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据